主要文件

查看所有文档

SM-2004

Low Trypsin-High EDTA

Name: Low Trypsin-High EDTA
Brand: MM

PBS Based, 0.025% Trypsin & 0.75mM EDTA (1X), without Ca 2+ & Mg 2+

别名:

Low Trypsin-High EDTA Solution, PBS-Based Trypsin Solution, Trypsin-EDTA PBS

登录查看组织和合同定价。

选择尺寸

变更视图

关于此项目

UNSPSC Code:

12352204

eCl@ss:

32160801

NACRES:

NA.75

技术服务

需要帮助？我们经验丰富的科学家团队随时乐意为您服务。

让我们为您提供帮助

属性

产品名称

Low Trypsin-High EDTA, PBS Based, 0.025% Trypsin and 0.75mM EDTA (1X), without Ca²⁺ and Mg²⁺, The Low Trypsin-High EDTA, PBS Based, 0.025% Trypsin & 0.75mM EDTA (1X), without Ca 2+ & Mg 2+ is available in a 100 mL format.

Quality Level

200

form

liquid

manufacturer/tradename

Specialty Media

input

sample type: human embryonic stem cell(s)
sample type induced pluripotent stem cell(s)
sample type epithelial cells
sample type hematopoietic stem cell(s)
sample type mesenchymal stem cell(s)
sample type neural stem cell(s)
sample type pancreatic stem cell(s)
sample type: mouse embryonic stem cell(s)
sample type cardiac stem cell(s)

说明

Application

Low Trypsin-High EDTA, PBS Based, 0.025% Trypsin and 0.75mM EDTA (1X), without Ca²⁺ and Mg²⁺ has been used:

as an incubating medium for single-cell preparation of human islets
in the preparation of mouse embryonic fibroblast cells stock for conventional gene targeting
to trypsinize human umbilical vein endothelial cells (HUVECs) for coating the beads with HUVECs

Preparation Note

Store at -20°C for 18 months.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

存储类别

12 - Non Combustible Liquids

flash_point_f

Not applicable

flash_point_c

Not applicable

分析证书(COA)

输入产品批号来搜索分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Cannabinoids inhibit angiogenic capacities of endothelial cells via release of tissue inhibitor of matrix metalloproteinases-1 from lung cancer cells.

Robert Ramer et al.

Biochemical pharmacology, 91(2), 202-216 (2014-07-01)

Cannabinoids inhibit tumor neovascularization as part of their tumorregressive action. However, the underlying mechanism is still under debate. In the present study the impact of cannabinoids on potential tumor-to-endothelial cell communication conferring anti-angiogenesis was studied. Cellular behavior of human umbilical

全球贸易项目编号

货号	GTIN
SM-2004-C	04053252667916